Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" ...

FuelCell Energy and Bloom Energy have spent 2025 riding the same AI data center power wave, but Monday's trading just cracked that story wide open and forced investors to pick a side.

Deep Origin docking software and molecular dynamics simulations pinpointed the lead compound from a 17-compound library ...

The fashion ecommerce giant has joined Sereact's Series B as a strategic investor, betting that the startup's physical AI can ...

Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, ...

Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune "brakes" exploited by tumors to evade attack-show limited efficacy in some brain tumors.

Summary: Researchers demonstrated that the success of anti-CTLA-4 immunotherapy against brain tumors does not depend on local ...

Researchers find that key antiviral proteins were unable to effectively combat the coronavirus in certain patients ...

Dr. Javin Oza said building synthetic cells in a lab environment is “kind of like rebuilding a car from its parts.” ...

Atlanta is home to the world's largest production test cell. Tour with us at Delta TechOps, guided by Duty Manager Mark Folsom.

Unlike bacteria, fungi are remarkably difficult to attack without also harming human cells. That biological reality has left medicine with surprisingly few antifungal drugs—and made the emergence of ...

Medulloblastoma is the most common malignant embryonal tumor of the central nervous system in the pediatric population, ...